01 44TAKEDA PHARMS USA
01 117807689
02 118173663
03 118288539
04 68637079
05 38697125
06 28900638
01 22Y
02 22Blank
01 22Y
02 22Blank
01 172025-03-15
02 22025-06-24
03 32025-12-02
04 112028-06-27
05 22029-05-24
06 62029-06-04
07 32029-06-16
Patent Expiration Date : 2028-06-27
US Patent Number : 7807689
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22271
Patent Use Code : U-1337
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2028-06-27
Patent Expiration Date : 2028-06-27
US Patent Number : 7807689
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22271
Patent Use Code : U-1337
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2028-06-27
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2028-06-27
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 7807689
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22426
Patent Use Code : U-1337
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2028-06-27
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2028-06-27
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 7807689
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22426
Patent Use Code : U-1337
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2028-06-27
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
